SCHEMBL20157464

SCHEMBL20157464

COCCOc1ncc2nc(C)[nH]c2n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.36
▸ CYP1A2 P05177 6/20 0.35
▸ CYP3A4 P08684 5/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ TRPV1 Q8NER1 1/20 0.33
▸ NUDT1 P36639 2/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ TLR7 Q9NYK1 2/20 0.32
▸ CD38 P28907 1/20 0.31
▸ CYP2C19 P33261 3/20 0.31
▸ KRAS P01116 1/20 0.31
▸ SOS1 Q07889 1/20 0.31
▸ FGFR1 P11362 1/20 0.31
▸ FGFR2 P21802 1/20 0.31
▸ FGFR3 P22607 1/20 0.31
▸ CBFB Q13951 2/20 0.30
▸ ACACB O00763 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30
▸ USP2 O75604 1/20 0.30
▸ TRIM33 Q9UPN9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21514305 0.80 TRPV1 (0.41) TSHRCYP1A2CYP3A4ALDH1A1TRPV1
SCHEMBL13377819 0.71 PARP1 (0.30) ALDH1A1
SCHEMBL20157656 0.71 TYRO3 (0.49) FGFR1
SCHEMBL9797808 0.70 PDK2 (0.40) ALDH1A1USP2
SCHEMBL25680732 0.68 TSHR (0.39) TSHRCYP1A2CYP3A4ALDH1A1NUDT1
SCHEMBL20157445 0.68 PDE3B (0.45) CYP1A2ALDH1A1NUDT1TLR7
SCHEMBL8525361 0.67 TYMS (0.32) ALDH1A1
SCHEMBL29882178 0.67 TSHR (0.38) TSHRCYP1A2CYP3A4ALDH1A1MAPK1
SCHEMBL21514178 0.67 TSHR (0.38) TSHRCYP1A2CYP3A4ALDH1A1MAPK1
SCHEMBL716117 0.66 TSHR (0.50) TSHRCYP1A2CYP3A4ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539963-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PREPARATION METHOD, INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND USE Livo (Shanghai) Pharmaceutical Co., Ltd (CN) 2019-09-18 — — EP disclosed
WO-2018086593-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PREPARATION METHOD, INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND USE 礼沃(上海)医药科技有限公司 2018-05-17 — — WO disclosed
Send feedback